Colchicine – Page 7 – Communicable Diseases Research

Colchicine, COVID-19 and hematological parameters: A meta-analysis

콜히친, COVID-19 및 혈액 학적 파라미터 : 메타 분석

Meta-Analysis

Published on 2021-12-012022-08-31
Journal: Journal of Clinical Laboratory Analysis [Category] MERS, 바이오마커,

[키워드] adjunct Anti-inflammatory anti-inflammatory properties Biomarker C-reactive protein C-reactive protein (CRP clinical and laboratory parameters ClinicalTrials Colchicine colchicine group conducted COVID-19 COVID-19 infection COVID-19 patients COVID-19 treatment CRP D-dimer D-dimer value D-dimer values database databases determine Direct effect size Efficacy Elsevier Google Scholar hematological Inflammatory Inflammatory biomarker inflammatory biomarkers item Laboratory laboratory parameter Lactate lactate dehydrogenase LDH Meta-analysis moderate-to-severe COVID-19 patients morbidity and mortality Other Patient post treatment PRISMA Protein reducing reduction reductions in reported Reporting review SAGE SARS-CoV-2 Science Science Direct searched significant reductions SMD Treatment Trial trials Web of Science
[DOI] 10.1002/jcla.24057 PMC 바로가기 [Article Type] Meta-Analysis

ESCMID COVID-19 living guidelines: drug treatment and clinical management

Guidelines

Published on 2021-11-222022-10-04
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료법, 치료제,

[키워드] addressed Antibiotics approach Bacterial Clinical management clinician Colchicine Combination Committee convalescent plasma coronavirus disease Corticosteroid Corticosteroids COVID-19 COVID-19 guideline develop Disease progression etesevimab Evidence Favipiravir Guidance guidelines hospitalized patients Immunocompromised Infection Infectious disease intensive care Interferon β-1a Intervention involved Ivermectin majority management monoclonal antibody Mortality outcome Outpatient outpatients oxygen patients with COVID-19 performed pharmacological treatment PICO Population Prophylaxis provided question recommendation Remdesivir selected severe COVID-19 severity Tocilizumab Treatment use of hydroxychloroquine utility was used were given
[DOI] 10.1016/j.cmi.2021.11.007 PMC 바로가기 [Article Type] Guidelines

Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?

Case Report

Published on 2021-11-182022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] Affect age Antigen autoantibodies autoantibody blunt BNT162b2 C-reactive protein children children with MIS-C Colchicine computer tomography Corona coronavirus COVID-19 COVID-19 mortality COVID-19 vaccination criteria diagnosed Diagnosis disease early stage elevated excluded Factor Fever Frequency functional Hashimoto thyroiditis higher risk Hospitalized IMPROVE Inflammatory initiated intravenous intravenous antibiotics Intravenous immunoglobulin MIS MIS-C mRNA Multisystem inflammatory syndrome occur pathophysiology pediatric Pneumonia positive receptor Release risk SARS-CoV infection SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2 vaccination second vaccination shown syndrome systemic inflammatory the disease the SARS-CoV-2 therapy treated troponin T vaccination Vaccine Vaccine hesitancy
[DOI] 10.3390/vaccines9111353 PMC 바로가기 [Article Type] Case Report

Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)

Randomized Controlled Trial

Published on 2021-11-092022-10-04
Journal: Journal of General Internal Medicine [Category] SARS, 임상,

[키워드] 95% CI 95%CI Adverse anti-inflammatory drug baseline clinical Colchicine colchicine treatment Complete conducted COVID-19 Critical disease death demonstrated Disease progression effective Efficacy evaluated event feature group had no hospital Hospitalized hospitalized patient ICU IL-12p70 IL-17A IL-8 immunological Ineffective interim analysis measure objective outcome participant Patient patients Placebo placebo-controlled clinical trial Primary outcome progression Randomized receive recruited recruitment Registration Result Safe Serum level severe COVID-19 severe COVID-19 patient suggested Treatment triple-blind
[DOI] 10.1007/s11606-021-07203-8 PMC 바로가기 [Article Type] Randomized Controlled Trial

Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial

Randomized Controlled Trial

Published on 2021-11-012022-10-05
Journal: Contemporary clinical trials [Category] SARS, 신약개발, 임상,

[키워드] 1:1 randomization addition Anti-inflammatory arterial/venous thromboembolic events benefit clinical Clinical improvement clinical trial Colchicine Combination Complication COVID-19 death defined Efficacy Efficiency Electronic health record Endpoint Enrollment Evidence Follow-up Health hospitalized COVID-19 patients IMPROVE Intervention intubation medication morbidity and mortality multicenter myocardial injury New Open-label Patient pleiotropic effect Pragmatic prevention prevention of COVID-19 primary endpoint progression randomization randomized trial Respiratory failure Safe severe COVID-19 disease Stage Standard of care statin Treatment Trial USA Verona World Health Organization
[DOI] 10.1016/j.cct.2021.106547 PMC 바로가기 [Article Type] Randomized Controlled Trial

Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine

Review

Published on 2021-10-312022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations

호흡기 질환 및 염증에 대한 식물 유래 천연 제품의 약리학 적 활동

Review

Published on 2021-10-042022-09-10
Journal: BioMed Research International [Category] 치료제,

Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations

Review

Published on 2021-10-042022-10-27
Journal: BioMed Research International [Category] COVID-19,

Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations

Review

Published on 2021-10-042022-10-27
Journal: BioMed Research International [Category] Coronavirus, COVID-19, MERS, SARS,

Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?

Article

Published on 2021-10-042022-10-28
Journal: Viruses [Category] COVID-19, MERS, SARS,